GRID THERAPEUTICS
Grid Therapeutics is a biotech company based on the innovative science first developed by Edward F. Patz, Jr. MD and his team of scientists at Duke University Medical Center. Located in Durham, North Carolina, Grid is developing the first human derived targeted immunotherapy for cancer. The antibody was discovered in exceptional outcome early stage lung cancer patients and was isolated from patient’s B-cells using state of the art molecular genomic techniques. “GT103”, the company’s lead asset, is expected to enter a first-in-man Phase 1 clinical trial in advanced-stage solid tumor patients in early 2019.
GRID THERAPEUTICS
Industry:
Biotechnology Life Science Medical Device
Founded:
2014-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.gridtherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
+1 919 987 7190
Email Addresses:
[email protected]
Total Funding:
5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins Global Site Tag
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
Jeffery “TJ” Heyman
Jeffery “TJ” Heyman investment in Series B - Grid Therapeutics
Milestone Holdings
Milestone Holdings investment in Series B - Grid Therapeutics
Paul Funk
Paul Funk investment in Series B - Grid Therapeutics
Longview International
Longview International investment in Series A - Grid Therapeutics
Official Site Inspections
http://www.gridtherapeutics.com
- Host name: 204.238.174.34.bc.googleusercontent.com
- IP address: 34.174.238.204
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Grid Therapeutics"
Board of Directors - Grid Therapeutics
Paolo Paoletti is currently the CEO at GammaDelta Therapeutics, a biotech company focused on leveraging gamma delta T cells which are a unique and conserved population of lymphocytes …See details»
Management Team - Grid Therapeutics
Grid Therapeutics is an emerging clinical stage biotechnology company located in Durham, North Carolina. We have made a commitment to our patients and families to develop better and …See details»
Grid Therapeutics, LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Grid Therapeutics, LLC of Chapel Hill, NC. Get the latest business insights from Dun & Bradstreet.See details»
Grid Therapeutics - Crunchbase Company Profile & Funding
Grid develops an innovative platform to develop human derived antibodies focusing on cancer therapeutics.See details»
Grid Therapeutics LLC: Drug pipelines, Patents, Clinical trials
Jun 19, 2023 Please refer to for additional clinical trial details. About SITC Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical …See details»
Grid Therapeutics - LinkedIn
Grid Therapeutics is a biotech company based on the innovative science first developed by Edward F. Patz, Jr. MD and his team of scientists at Duke University Medical Center. Located …See details»
Grid Therapeutics LLC | North Carolina Biotech Center
Grid Therapeutics LLC Grid Therapeutics is developing cancer therapeutics that utilize a unique platform that develops human-derived antibodies for the treatment of multiple cancer types.See details»
Grid Therapeutics - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Grid Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Grid Therapeutics - VentureRadar
Grid Therapeutics is a biotech company built on the innovative science developed by Edward F. Patz, Jr. MD and his team of scientists at Duke University Medical Center. Located in Durham, …See details»
Grid Therapeutics - Duke OTC
Grid Therapeutics Innovative Platform To Develop Completely Human-Derived Antibodies For The Treatment Of Multiple Cancer Types. Grid Therapeutics is an emerging bio-therapeutic …See details»
Grid Therapeutics - Overview, News & Similar companies
Feb 22, 2023 View Grid Therapeutics (www.gridtherapeutics.com) location in North Carolina, United States , revenue, industry and description. Find related and similar companies as well …See details»
Contact Us - Grid Therapeutics
Ryan Dackor, Ph.D. Director, Clinical Operations 919.270.9404 [email protected]See details»
Grid Therapeutics - Company Profile - Tracxn
Grid Therapeutics - Developer of therapeutic antibodies. Raised a total funding of $6.45M over 4 rounds from 4 investors.See details»
Grid Therapeutics - VentureRadar
"Grid Therapeutics is a biotech company built on the innovative science developed by Edward F. Patz, Jr. MD and his team of scientists at Duke University Medical Center. Located in Durham, …See details»
Grid Therapeutics Announces Upcoming Scientific Presentation at …
Nov 3, 2022 Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by …See details»
Grid Therapeutics, LLC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Grid Therapeutics, LLC of Chapel Hill, NC. Get the latest business insights from Dun & Bradstreet.See details»
Durham’s Grid Therapeutics Gets FDA OK to Test Cancer …
Apr 14, 2020 Grid Therapeutics has received clearance from the U.S. Food and Drug Administration to begin human testing of its new cancer immunotherapy.See details»
Grid Therapeutics Signs Exclusive Agreement to Develop a Novel …
Aug 22, 2017 Grid Therapeutics announced the execution of an exclusive license agreement with Duke University to develop the first human derived antibody as a targeted immunotherapy …See details»
Pipeline - Grid Therapeutics
A paradigm shift in antibody discovery for cancer We have developed an advanced, innovative and efficient high-throughput single B cell culturing platform to rapidly discover and generate …See details»